Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CTSS | P25774 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 1/20 | 0.43 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.41 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24404141 | 1.00 | ALDH1A1 (0.44) | ALDH1A1HPGDMAPTGAASMN1; SMN2 | |
| SCHEMBL24404144 | 0.91 | ALDH1A1 (0.49) | ALDH1A1HPGDMAPTGAASMN1; SMN2 | |
| SCHEMBL20583689 | 0.91 | ALDH1A1 (0.49) | ALDH1A1HPGDMAPTGAASMN1; SMN2 | |
| SCHEMBL20583668 | 0.89 | GAA (0.41) | ALDH1A1HPGDMAPTGAASMN1; SMN2 | |
| SCHEMBL24404136 | 0.89 | TSHR (0.43) | ALDH1A1HPGDMAPTGAASMN1; SMN2 | |
| SCHEMBL20583417 | 0.89 | TSHR (0.43) | ALDH1A1HPGDMAPTGAASMN1; SMN2 | |
| SCHEMBL24404076 | 0.88 | POLB (0.42) | ALDH1A1GAAABCC4LMNATSHR | |
| SCHEMBL20583506 | 0.88 | POLB (0.42) | ALDH1A1GAAABCC4LMNATSHR | |
| SCHEMBL28538183 | 0.88 | ALDH1A1 (0.42) | ALDH1A1HPGDMAPTGAASMN1; SMN2 | |
| SCHEMBL24404086 | 0.86 | ALDH1A1 (0.45) | ALDH1A1HPGDMAPTGAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11370739-B2 | Sacubitril intermediate and preparation method thereof | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2022-06-28 | — | — | US | disclosed |
| US-11370739-B2 | Sacubitril intermediate and preparation method thereof | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2022-06-28 | — | — | US | disclosed |
| EP-3424899-B1 | SACUBITRIL INTERMEDIATE AND PREPARATION METHOD THEREOF | SUNSHINE LAKE PHARMA CO LTD (CN) | 2022-05-11 | — | — | EP | disclosed |
| EP-3424899-B1 | SACUBITRIL INTERMEDIATE AND PREPARATION METHOD THEREOF | SUNSHINE LAKE PHARMA CO LTD (CN) | 2022-05-11 | — | — | EP | disclosed |
| CN-106977415-B | Intermediate of shakubiqu and preparation method thereof | 广东东阳光药业有限公司 | 2021-03-26 | — | — | CN | disclosed |
| US-20200079721-A1 | SACUBITRIL INTERMEDIATE AND PREPARATION METHOD THEREOF | NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED (HK) | 2020-03-12 | — | — | US | disclosed |
| US-10479753-B2 | Sacubitril intermediate and preparation method thereof | SUNSHINE LAKE PHARMA CO., LTD (CN) | 2019-11-19 | — | — | US | disclosed |
| US-10479753-B2 | Sacubitril intermediate and preparation method thereof | SUNSHINE LAKE PHARMA CO., LTD (CN) | 2019-11-19 | — | — | US | disclosed |
| EP-3424899-A1 | SACUBITRIL INTERMEDIATE AND PREPARATION METHOD THEREOF | Sunshine Lake Pharma Co., Ltd. (CN) | 2019-01-09 | — | — | EP | disclosed |
| EP-3424899-A1 | SACUBITRIL INTERMEDIATE AND PREPARATION METHOD THEREOF | Sunshine Lake Pharma Co., Ltd. (CN) | 2019-01-09 | — | — | EP | disclosed |
| US-20180362439-A1 | SACUBITRIL INTERMEDIATE AND PREPARATION METHOD THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2018-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200079721-A1 | SACUBITRIL INTERMEDIATE AND PREPARATION METHOD THEREOF | DPP4, ACE, DPP8 | ALDH1A1 308/4885HPGD 1169/4885MAPT 1710/4885 |
| US-20180362439-A1 | SACUBITRIL INTERMEDIATE AND PREPARATION METHOD THEREOF | ACE, DPP4, SI | ALDH1A1 339/4885HPGD 1551/4885MAPT 1322/4885 |
| US-11370739-B2 | Sacubitril intermediate and preparation method thereof | DPP4, ACE, DPP8 | ALDH1A1 308/4885HPGD 1169/4885MAPT 1710/4885 |
| US-10479753-B2 | Sacubitril intermediate and preparation method thereof | ACE, DPP4, SI | ALDH1A1 339/4885HPGD 1551/4885MAPT 1322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.